“ID:2037 Molecular mechanisms underlying resistance to MEK1/2 inhibitor in BRAF-mutated colorectal cancer”, Biomed. Res. Ther., vol. 4, no. S, p. S68, Sep. 2017, doi: 10.15419/bmrat.v4iS.276.